SI0998291T1 - Zdravljenje diabetesa s tiazolidindionom in sulfonilseäśnino - Google Patents

Zdravljenje diabetesa s tiazolidindionom in sulfonilseäśnino

Info

Publication number
SI0998291T1
SI0998291T1 SI9830892T SI9830892T SI0998291T1 SI 0998291 T1 SI0998291 T1 SI 0998291T1 SI 9830892 T SI9830892 T SI 9830892T SI 9830892 T SI9830892 T SI 9830892T SI 0998291 T1 SI0998291 T1 SI 0998291T1
Authority
SI
Slovenia
Prior art keywords
sulphonylurea
thiazolidinedione
diabetes
treatment
Prior art date
Application number
SI9830892T
Other languages
English (en)
Other versions
SI0998291T2 (sl
Inventor
Robin Edwin Smithkl Buckingham
Stephen Alistair Smithkl Smith
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10816177&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI0998291(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of SI0998291T1 publication Critical patent/SI0998291T1/sl
Publication of SI0998291T2 publication Critical patent/SI0998291T2/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
SI9830892T 1997-07-18 1998-07-16 Zdravljenje diabetesa s tiazolidindionom in sulfonilseäśnino SI0998291T2 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9715306A GB9715306D0 (en) 1997-07-18 1997-07-18 Novel method of treatment
EP98935126A EP0998291B2 (en) 1997-07-18 1998-07-16 Treatment of diabetes with thiazolidinedione and sulphonylurea
PCT/GB1998/002109 WO1999003476A1 (en) 1997-07-18 1998-07-16 Treatment of diabetes with thiazolidinedione and sulphonylurea

Publications (2)

Publication Number Publication Date
SI0998291T1 true SI0998291T1 (sl) 2007-12-31
SI0998291T2 SI0998291T2 (sl) 2011-10-28

Family

ID=10816177

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9830892T SI0998291T2 (sl) 1997-07-18 1998-07-16 Zdravljenje diabetesa s tiazolidindionom in sulfonilseäśnino

Country Status (41)

Country Link
EP (1) EP0998291B2 (sl)
JP (2) JP2001510158A (sl)
KR (1) KR100680667B1 (sl)
CN (1) CN1264302A (sl)
AP (1) AP1318A (sl)
AR (2) AR016768A1 (sl)
AT (1) ATE366577T1 (sl)
AU (1) AU743269B2 (sl)
BG (1) BG64892B1 (sl)
BR (1) BR9810904A (sl)
CA (1) CA2297115C (sl)
CO (1) CO4940422A1 (sl)
CY (1) CY1107745T1 (sl)
CZ (1) CZ302668B6 (sl)
DE (1) DE69838066T3 (sl)
DK (1) DK0998291T4 (sl)
DZ (1) DZ2564A1 (sl)
EA (1) EA003303B1 (sl)
ES (1) ES2290989T5 (sl)
GB (1) GB9715306D0 (sl)
HK (1) HK1029272A1 (sl)
HU (1) HU229119B1 (sl)
ID (1) ID24198A (sl)
IL (1) IL134045A0 (sl)
IN (1) IN189035B (sl)
MA (1) MA26522A1 (sl)
MY (1) MY138246A (sl)
NO (1) NO326356B1 (sl)
NZ (3) NZ520652A (sl)
OA (1) OA11632A (sl)
PE (1) PE99799A1 (sl)
PL (2) PL199125B1 (sl)
PT (1) PT998291E (sl)
SI (1) SI0998291T2 (sl)
SK (2) SK287823B6 (sl)
TR (1) TR200000135T2 (sl)
TW (1) TW586926B (sl)
UA (1) UA70302C2 (sl)
UY (1) UY25103A1 (sl)
WO (1) WO1999003476A1 (sl)
ZA (1) ZA986365B (sl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1897547A1 (en) * 1999-07-13 2008-03-12 Medicure Inc. Use of pyridoxal phosphate derivatives for the treatment of diabetes and related complications
EP1832291A3 (en) * 1999-07-13 2009-11-04 Medicure Inc. use of pyridoxal phosphate for the treatment of diabetes and related complications
US6586438B2 (en) 1999-11-03 2003-07-01 Bristol-Myers Squibb Co. Antidiabetic formulation and method
US20010036479A1 (en) 2000-01-14 2001-11-01 Gillian Cave Glyburide composition
MXPA03006217A (es) 2001-01-12 2004-10-15 Sun Pharmaceutical Ind Ltd Sistema de administracion espaciada de farmacos.
BRPI0414979A (pt) * 2003-10-31 2006-11-21 Takeda Pharmaceutical preparação sólida
JP2008019169A (ja) * 2004-10-25 2008-01-31 Osaka Univ 新規ｐｐａｒ調節剤およびそのスクリーニング方法
PE20110019A1 (es) 2005-12-22 2011-01-27 Takeda Pharmaceutical Composicion farmaceutica que contiene un sensibilizante de insulina y un secretagogo de insulina

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5522636A (en) * 1978-08-04 1980-02-18 Takeda Chem Ind Ltd Thiazoliding derivative
JPS5697277A (en) * 1980-01-07 1981-08-05 Takeda Chem Ind Ltd Thiazolidine derivative
JPS6051189A (ja) * 1983-08-30 1985-03-22 Sankyo Co Ltd チアゾリジン誘導体およびその製造法
US4582839A (en) * 1984-03-21 1986-04-15 Takeda Chemical Industries, Ltd. 2,4-thiazolidinediones
CN1003445B (zh) * 1984-10-03 1989-03-01 武田药品工业株式会社 噻唑烷二酮衍生物，其制备方法和用途
JPH06779B2 (ja) * 1985-06-10 1994-01-05 武田薬品工業株式会社 チアゾリジオン誘導体およびそれを含んでなる医薬組成物
US4812570A (en) * 1986-07-24 1989-03-14 Takeda Chemical Industries, Ltd. Method for producing thiazolidinedione derivatives
EP0842925A1 (en) * 1987-09-04 1998-05-20 Beecham Group Plc Substituted thiazolidinedione derivatives
US4791125A (en) * 1987-12-02 1988-12-13 Pfizer Inc. Thiazolidinediones as hypoglycemic and anti-atherosclerosis agents
WO1989008651A1 (en) * 1988-03-08 1989-09-21 Pfizer Inc. Hypoglycemic thiazolidinedione derivatives
US5061717A (en) * 1988-03-08 1991-10-29 Pfizer Inc. Thiazolidinedione hypoglycemic agents
WO1991007107A1 (en) * 1989-11-13 1991-05-30 Pfizer Inc. Oxazolidinedione hypoglycemic agents
JPH04210683A (ja) * 1990-12-06 1992-07-31 Terumo Corp チアゾリジン−２，４−ジオン誘導体およびこれを含有する糖尿病合併症治療薬
US5183823A (en) * 1991-04-11 1993-02-02 Takeda Chemical Industries, Ltd. Pyridine n-oxide compounds which are useful as hypoglycemic and hypolipidemic agents
ATE139130T1 (de) * 1991-08-16 1996-06-15 Sandoz Ag Inhalator zur verabreichung von pulverförmigen substanzen
US5900435A (en) * 1991-08-26 1999-05-04 Pharmacia & Upjohn Company Composition, food product and uses of 3-guanidinopropionic acid
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
TWI238064B (en) * 1995-06-20 2005-08-21 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes
US5859037A (en) * 1997-02-19 1999-01-12 Warner-Lambert Company Sulfonylurea-glitazone combinations for diabetes

Also Published As

Publication number Publication date
AP1318A (en) 2004-10-22
BG104139A (en) 2000-11-30
ES2290989T3 (es) 2008-02-16
NO20000229L (no) 2000-01-17
CY1107745T1 (el) 2013-04-18
TW586926B (en) 2004-05-11
IL134045A0 (en) 2001-04-30
PE99799A1 (es) 1999-12-22
EP0998291A1 (en) 2000-05-10
OA11632A (en) 2004-11-22
MA26522A1 (fr) 2004-12-20
UA70302C2 (uk) 2004-10-15
DZ2564A1 (fr) 2003-02-15
CN1264302A (zh) 2000-08-23
NO20000229D0 (no) 2000-01-17
ID24198A (id) 2000-07-13
PL338127A1 (en) 2000-09-25
DK0998291T4 (da) 2011-09-26
CA2297115A1 (en) 1999-01-28
WO1999003476A1 (en) 1999-01-28
AR019331A2 (es) 2002-02-13
EP0998291B1 (en) 2007-07-11
DE69838066T2 (de) 2008-03-20
EA003303B1 (ru) 2003-04-24
ES2290989T5 (es) 2011-11-11
DK0998291T3 (da) 2007-11-05
CO4940422A1 (es) 2000-07-24
PL199125B1 (pl) 2008-08-29
GB9715306D0 (en) 1997-09-24
EP0998291B2 (en) 2011-07-06
EA200000141A1 (ru) 2000-08-28
AR016768A1 (es) 2001-08-01
SK288053B6 (sk) 2013-03-01
TR200000135T2 (tr) 2000-05-22
KR100680667B1 (ko) 2007-02-09
DE69838066T3 (de) 2012-03-29
HU229119B1 (en) 2013-08-28
IN189035B (sl) 2002-12-07
PT998291E (pt) 2007-10-11
JP2005247865A (ja) 2005-09-15
UY25103A1 (es) 2000-12-29
MY138246A (en) 2009-05-29
ZA986365B (en) 2000-01-17
BG64892B1 (bg) 2006-08-31
NO326356B1 (no) 2008-11-17
ATE366577T1 (de) 2007-08-15
JP2001510158A (ja) 2001-07-31
SI0998291T2 (sl) 2011-10-28
NZ520652A (en) 2004-06-25
CA2297115C (en) 2010-02-23
CZ2000173A3 (en) 2001-05-16
AU8448798A (en) 1999-02-10
AP2000001734A0 (en) 2000-03-31
DE69838066D1 (de) 2007-08-23
AU743269B2 (en) 2002-01-24
HK1029272A1 (en) 2001-03-30
SK602000A3 (en) 2000-07-11
HUP0003634A2 (hu) 2001-07-30
BR9810904A (pt) 2000-09-26
KR20010021948A (ko) 2001-03-15
SK287823B6 (sk) 2011-11-04
CZ302668B6 (cs) 2011-08-24
NZ515555A (en) 2002-09-27
HUP0003634A3 (en) 2003-04-28
NZ501256A (en) 2002-09-27

Similar Documents

Publication Publication Date Title
AP9901719A0 (en) Treatment of diabetes with thiazolidinedione and metormin
HUP0003876A3 (en) Use of thiazolidinedione derivatives in the treatment of polycystic ovary syndrome and gestational diabetes
HUP0203367A3 (en) Benzylidine-thiazolidinediones and analogues and their use in the treatment of diabetes
HK1045111A1 (en) (3-Trihalomethylphenoxy) (4-halophenyl) for the treatment of insulin reisistance and type 2 diabetes
IL127219A0 (en) The use of insulin sensitivity enhancers for treatment of hyperuricemia and compositions containing insulin sensitivity enhancers for treating the same
AU5840200A (en) Treatment of diabetes and related pathologies
AP2000001733A0 (en) Treatment of diabetes with thiazolidinedione insulin secretagogue and diguanide
PL343123A1 (en) Treatment of diabetes with rosiglitazone and insulin
HK1028200A1 (en) Treatment of diabetes with thiazolidinedione and sulphonylurea
IL134045A0 (en) Treatment of diabetes with thiazolidinedione and sulphonylurea
IL133907A0 (en) Treatment of diabetes with thiazolidinedione, insulin secretagogue and alpha glucocidase inhibitor
PL337577A1 (en) Treatment of diabetes with thiazolydinone and alpha - glucosidaze inhibitor
AU4107797A (en) Compounds for the treatment and prevention of diabetes
HUP0002669A3 (en) Treatment of diabetes with thiazolidinedione and sulphonylurea
EP1126856A4 (en) COMPOUNDS AND ITS THERAPEUTIC USE IN DIABETIC COMPLICATIONS
HUP0002668A3 (en) Treatment of diabetes with thiazolidinedione and metformin
ZA989514B (en) Treatment of diabetic retinopathy
IL121656A0 (en) Diagnosis prevention and treatment of diabetes
GB9609897D0 (en) Treatment of diabetes